Fig. 2From: Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort studyAnticoagulation dosage in therapeutic and prophylactic groups at days 1, 3 and 7 after ICU admission. IU international unit, LMWH low molecular weight heparin, UFH unfractionated heparinBack to article page